Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rassool

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2022
A Randomized Clinical Trial of Human Papillomavirus Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women With Human Immunodeficiency Virus: AIDS Clinical Trials Group Protocol A5282Timothy Wilkin, Huichao Chen, Vikrant Sahasrabuddhe, et al.
Circulation|October 29, 2013
Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculatureTea Soon Park, Imran Bhutto, Ludovic Zimmerlin, et al.
The New England Journal of Medicine|December 22, 2022
A 24-Week, All-Oral Regimen for Rifampin-Resistant TuberculosisBern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2023
Performance of spirometry assessment at TB diagnosisA Rachow, O Ivanova, A Bakuli, et al.
Lancet (London, England)|June 19, 2010
Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trialIan Sanne, Catherine Orrell, Matthew P Fox, et al.
The Lancet. Respiratory Medicine|November 19, 2023
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trialBern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis, et al.
Cancer Cell|May 10, 2017
CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor GenesLimin Xia, Wenjie Huang, Marina Bellani, et al.
Blood|July 10, 2013
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profileKimberly Cramer-Morales, Margaret Nieborowska-Skorska, Kara Scheibner, et al.
The Lancet. HIV|September 15, 2015
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS StudyJuan G Sierra-Madero, Susan Ellenberg, Mohammed S Rassool, et al.
AIDS (London, England)|July 26, 2017
Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adultsGregory P Bisson, Ritesh Ramchandani, Sachiko Miyahara, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2022
A Randomized Clinical Trial of Human Papillomavirus Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women With Human Immunodeficiency Virus: AIDS Clinical Trials Group Protocol A5282Timothy Wilkin, Huichao Chen, Vikrant Sahasrabuddhe, et al.
Circulation|October 29, 2013
Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculatureTea Soon Park, Imran Bhutto, Ludovic Zimmerlin, et al.
The New England Journal of Medicine|December 22, 2022
A 24-Week, All-Oral Regimen for Rifampin-Resistant TuberculosisBern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2023
Performance of spirometry assessment at TB diagnosisA Rachow, O Ivanova, A Bakuli, et al.
Lancet (London, England)|June 19, 2010
Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trialIan Sanne, Catherine Orrell, Matthew P Fox, et al.
The Lancet. Respiratory Medicine|November 19, 2023
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trialBern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis, et al.
Cancer Cell|May 10, 2017
CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor GenesLimin Xia, Wenjie Huang, Marina Bellani, et al.
Blood|July 10, 2013
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profileKimberly Cramer-Morales, Margaret Nieborowska-Skorska, Kara Scheibner, et al.
The Lancet. HIV|September 15, 2015
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS StudyJuan G Sierra-Madero, Susan Ellenberg, Mohammed S Rassool, et al.
AIDS (London, England)|July 26, 2017
Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adultsGregory P Bisson, Ritesh Ramchandani, Sachiko Miyahara, et al.
Pageof 23